بدائل البحث:
significant treatment » significant investment (توسيع البحث), significant enrichment (توسيع البحث), significant impairment (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
treatment decrease » treatment decreased (توسيع البحث), treatments decreased (توسيع البحث), treatment increases (توسيع البحث)
significant treatment » significant investment (توسيع البحث), significant enrichment (توسيع البحث), significant impairment (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
treatment decrease » treatment decreased (توسيع البحث), treatments decreased (توسيع البحث), treatment increases (توسيع البحث)
-
1641
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
-
1642
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
-
1643
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
منشور في 2025"…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
-
1644
-
1645
-
1646
-
1647
-
1648
-
1649
-
1650
-
1651
-
1652
-
1653
-
1654
-
1655
Synthesis and Biological Evaluation of MEK/mTOR Multifunctional Inhibitors as Novel Anticancer Agents
منشور في 2025"…Additionally, compound LP-65 demonstrated significant modulation of MEK and mTOR signaling activity in human glioma cells (D54) and human melanoma cells (A375), with a corresponding decrease in cellular proliferation and migration. …"
-
1656
-
1657
-
1658
-
1659
-
1660